--- title: "DUALITYBIO-B has been included in the Hang Seng Composite Index and is expected to become a target for the Hong Kong Stock Connect" description: "DUALITYBIO-B has been included in the Hang Seng Composite Index, with the change to be implemented after the market closes on September 5 and effective from September 8. Huatai Securities pointed out " type: "news" locale: "en" url: "https://longbridge.com/en/news/254179419.md" published_at: "2025-08-22T12:47:04.000Z" --- # DUALITYBIO-B has been included in the Hang Seng Composite Index and is expected to become a target for the Hong Kong Stock Connect > DUALITYBIO-B has been included in the Hang Seng Composite Index, with the change to be implemented after the market closes on September 5 and effective from September 8. Huatai Securities pointed out that the company meets the standards for market capitalization, liquidity, and listing time, and is expected to be included in the Hong Kong Stock Connect. Its key product DB-1310 has been granted Fast Track designation by the FDA for the treatment of certain types of advanced non-small cell lung cancer According to the Zhitong Finance APP, on August 22, the Hang Seng Index Company announced the results of the quarterly review of the Hang Seng Index series as of June 30, 2025, in which DUALITYBIO-B (09606) was included in the Hang Seng Composite Index. The changes will be implemented after the market closes on September 5 (Friday) and will take effect on September 8 (Monday). At that time, the Shanghai and Shenzhen Stock Exchanges will adjust the scope of investable stocks under the Hong Kong Stock Connect accordingly. According to a research report from Huatai Securities, DUALITYBIO-B may be included in the Hong Kong Stock Connect as it meets a series of criteria including market capitalization, liquidity, and listing time. DUALITYBIO announced that its key product DB-1310 (an antibody-drug conjugate targeting human epidermal growth factor receptor 3 (HER3)) has been granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for the treatment of adult patients with advanced/unresectable or metastatic non-squamous non-small cell lung cancer (nsqNSCLC) who have disease progression during or after treatment with third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) and platinum-based chemotherapy, and who carry EGFR exon 19 deletions or L858R mutations. It is reported that DB-1310 is a next-generation ADC product targeting HER3 developed using the company's proprietary DITAC technology platform. In June 2025, DUALITYBIO presented the first human Phase I/IIa clinical study (NCT05785741) data of DB-1310 at the 2025 American Society of Clinical Oncology (ASCO) annual meeting, with Dr. Aaron E. Lisberg from the University of California, Los Angeles (UCLA) delivering the oral presentation. The results showed that DB-1310 demonstrated encouraging efficacy and controllable safety in patients with advanced solid tumors who failed standard treatment ### Related Stocks - [09606.HK - DUALITYBIO-B](https://longbridge.com/en/quote/09606.HK.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | 早盘趋势｜映恩生物资金再收缩，板块变盘机会在路上？ | 12 月 29 日映恩生物 -B 整日承压，资金持续围绕 10.3-10.5 元反复观望。生物医药板块整体陷入缩量盘整，行业缺乏重磅利好，投资者短线观望为主。MACD 短期均线死叉信号持续，弱势技术格局暂难改观。头部药企未有新药上市或合作订 | [Link](https://longbridge.com/en/news/270968880.md) | | Meta 加码英伟达：未来数年部署数百万颗芯片，首次采用 Grace CPU | 根据周二发布的声明，Meta 承诺将使用更多来自英伟达的 AI 处理器和网络设备。同时，Meta 还将首次在其独立计算机的核心部件采用英伟达的 Grace CPU。此次部署将涵盖基于英伟达当前 Blackwell 架构，以及即将推出的 Ve | [Link](https://longbridge.com/en/news/276177748.md) | | 摩尔线程快速完成对 Qwen3.5 模型全面适配 | 摩尔线程宣布已在旗舰级 AI 训推一体全功能 GPU MTT S5000 上完成对阿里最新大模型 Qwen3.5 的全方位适配。此次支持充分展示了摩尔线程 MUSA 生态的成熟度与完备性，开发者可通过 MUSA C 编程语言及 Triton | [Link](https://longbridge.com/en/news/276153560.md) | | 加拿大宣布新国防工业战略，注重国内制造以重获战备能力 | 加拿大总理卡尼于 2 月 17 日宣布新的国防工业战略，设定未来十年目标，包括将 70% 的国防合同授予本国企业，旨在实现国内采购和维护大部分军事装备。 | [Link](https://longbridge.com/en/news/276178964.md) | | 苹果加速研发 AI 眼镜、挂饰及摄像头版 AirPods | 作为向人工智能驱动硬件转型的一部分，苹果公司正加速开发三款新型可穿戴设备，包括智能眼镜、一款挂饰设备以及具备扩展 AI 功能的 AirPods。这些设备将围绕 Siri 数字助理构建，并依靠具备不同功能的摄像头系统，根据视觉语境执行操作。苹 | [Link](https://longbridge.com/en/news/276167877.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.